Rapt Therapeutics Inc. is a clinical-stage biotechnology company focused on discovering and developing oral small molecule therapies to treat cancer and inflammatory diseases.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!